Measures were taken in the US to reduce the risk posed by the concentrates made there. Read more about Measures were taken in the US to reduce the risk posed by the concentrates made there.
A special meeting of UKHCDO reference centre directors noted that there was insufficient evidence to warrant restriction of the use of imported concentrates in other patients in view of the immense benefits of therapy and that the situation would be kept under constant review. Read more about A special meeting of UKHCDO reference centre directors noted that there was insufficient evidence to warrant restriction of the use of imported concentrates in other patients in view of the immense benefits of therapy and that the situation would be kept under constant review.
The co-ordinator of the Haemophilia Society wrote to the Medical Advisory Panel of the Society to say that a group would be meeting with Geoffrey Finsberg to seek assurance that there would be no immediate ban on the importation of US blood products. Read more about The co-ordinator of the Haemophilia Society wrote to the Medical Advisory Panel of the Society to say that a group would be meeting with Geoffrey Finsberg to seek assurance that there would be no immediate ban on the importation of US blood products.
Dr Spence Galbraith wrote a paper entitled "Action on AIDS" which he sent to the DHSS. He had reviewed the literature and came to the conclusion that all blood products made from blood donated in the US after 1978 should be withdrawn from use until the risk of AIDS transmission by these products has been clarified. Read more about Dr Spence Galbraith wrote a paper entitled "Action on AIDS" which he sent to the DHSS. He had reviewed the literature and came to the conclusion that all blood products made from blood donated in the US after 1978 should be withdrawn from use until the risk of AIDS transmission by these products has been clarified.
A memo from Diana Walford to Dr Field discussed the recommendation to withdraw the use of American Factor 8 concentrate due to the risk of transmitting AIDS and noted that Dr Diana Walford thought this recommendation was premature as there was not sufficient evidence to restrict the use of imported Factor 8 concentrates. Read more about A memo from Diana Walford to Dr Field discussed the recommendation to withdraw the use of American Factor 8 concentrate due to the risk of transmitting AIDS and noted that Dr Diana Walford thought this recommendation was premature as there was not sufficient evidence to restrict the use of imported Factor 8 concentrates.
A memo enclosed a copy of the line to take in respect of Prime Minister's questions. The line called for a need to balance the risk of AIDS against the obvious risks to people with haemophilia from withdrawing supplies of blood products. Read more about A memo enclosed a copy of the line to take in respect of Prime Minister's questions. The line called for a need to balance the risk of AIDS against the obvious risks to people with haemophilia from withdrawing supplies of blood products.
At a meeting of the Association of Scientific, Technical and Managerial Staffs National Executive Council and Parliamentary Committee it was determined that a new problem had arisen with regards to the importation of blood products and the spread of AIDS. Read more about At a meeting of the Association of Scientific, Technical and Managerial Staffs National Executive Council and Parliamentary Committee it was determined that a new problem had arisen with regards to the importation of blood products and the spread of AIDS.
Professor Bloom suggested tests be performed to identify whether patients at the Cardiff Haemophilia Centre may have contracted illnesses. Read more about Professor Bloom suggested tests be performed to identify whether patients at the Cardiff Haemophilia Centre may have contracted illnesses.
Policy guidance for the treatment of haemophilia patients was issued at the Cardiff Haemophilia Centre. The guidance advised using DDVAP, cryoprecipitate and only NHS factor concentrates for children and those with mild haemophilia. Read more about Policy guidance for the treatment of haemophilia patients was issued at the Cardiff Haemophilia Centre. The guidance advised using DDVAP, cryoprecipitate and only NHS factor concentrates for children and those with mild haemophilia.
Haemophilia Treatment Policy Guidance stated to try to avoid using commercial factor concentrates and those who had never been given commercial concentrates should receive only NHS concentrates where concentrates were needed to limit exposure to risk. Read more about Haemophilia Treatment Policy Guidance stated to try to avoid using commercial factor concentrates and those who had never been given commercial concentrates should receive only NHS concentrates where concentrates were needed to limit exposure to risk.